News from Economic Times Markets
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Stocks
Investors
Crypto Assets
Cryptocurrency
Stock
Shares
Stock Market
Ethereum
Price
Markets
Xrp
Investment
Blockchain
Etf
Sec
Stablecoin
Eth
Bse
Trade
Index
Ipo
Solana
Earnings
Revenue
China
Coinbase
Inflation
Token
Wall Street
Nasdaq
Sensex
Interest Rates
Usd
Trade War
Gold
Economy
Traders
Tesla
Nse
Treasury
Profit
Digital Assets
Federal Reserve
Sp 500
Bse Sensex
Equity
Gmt
Salesforce
Collapse
Cycle Theory
Construction Sectors
Approved Persons Approach
Nypd
Bullish Signals
Mahindra Lifespaces
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search Economic Times Markets headlines…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Economic Times Markets • Jun 16, 2025
InCred bets on Camlin, midcap banks; Exits Adani Ports, Cipla amid tepid earnings outlook
InCred Equities has adjusted its portfolio by increasing exposure to select midcap stocks while divesting from larger companies, reflecting cautious optimism amid a slowing earning...
Read Full Article →
Economic Times Markets • Jun 12, 2025
Pharma stocks to buy: Cipla, Lupin, among 5 stocks with upside potential of up to 12%
Analysts highlight several pharmaceutical companies showing promising growth indicators, suggesting these stocks could potentially deliver returns approaching 12% in the near term.
Read Full Article →